Pharmosa Biopharm Inc. (6875.TWO)
TWD 47.0
(-9.96%)
TWD 47.0
(-9.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 195.99 Million TWD | 412.42% |
| 2022 | 38.24 Million TWD | -30.37% |
| 2021 | 54.93 Million TWD | -60.03% |
| 2020 | 137.44 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 216.42 Million TWD | 10.43% |
| 2024 Q2 | 225.1 Million TWD | 4.01% |
| 2023 Q3 | 196.49 Million TWD | 103.76% |
| 2023 Q2 | 96.43 Million TWD | 0.0% |
| 2023 FY | 195.99 Million TWD | 412.42% |
| 2023 Q1 | - TWD | -100.0% |
| 2023 Q4 | 195.99 Million TWD | -0.26% |
| 2022 Q4 | 38.24 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2702.259% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 66.41% |
| Level Biotechnology Inc. | 273.2 Million TWD | 28.262% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -42.203% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 0.75% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 85.24% |
| GlycoNex Incorporation | 276.39 Million TWD | 29.092% |
| VBI | 21.25 Million TWD | -822.262% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 37.524% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 61.918% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -823.349% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 46.79% |
| Visgeneer Inc. | 185.6 Million TWD | -5.595% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 85.188% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 73.261% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -63.516% |
| Neith Corporation | 17.43 Million TWD | -1024.247% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 91.274% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2861.469% |
| Enimmune corporation | 173.46 Million TWD | -12.987% |
| TaiRx, Inc. | 60.62 Million TWD | -223.282% |
| CHO Pharma, Inc. | 110.83 Million TWD | -76.835% |
| EirGenix Inc. | 1.14 Billion TWD | 82.884% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -75.021% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 61.753% |
| Lin BioScience, Inc. | 167.73 Million TWD | -16.849% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -109.136% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -210.927% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -57.133% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -21.688% |
| RBC Bioscience Corporation | 513.08 Million TWD | 61.801% |
| BiOptic Inc. | 170.56 Million TWD | -14.908% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -364.894% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -742.786% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -630.951% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 79.891% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2358.48% |
| NaviFUS Corp. | 53.4 Million TWD | -267.016% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 59.295% |
| Sinew Pharma Inc. | 39.71 Million TWD | -393.504% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -237.687% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 46.227% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 13.924% |
| AP Biosciences Inc | 106.65 Million TWD | -83.769% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 94.448% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -538.799% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 87.3% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 77.38% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2012.872% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -251.155% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 15.869% |
| TCI GENE Inc. | 155.54 Million TWD | -26.0% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -668.347% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -324.45% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 40.332% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -202.048% |
| PharmaEngine, Inc. | 91 Million TWD | -115.359% |
| Savior Lifetec Corporation | 457.95 Million TWD | 57.203% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -76.663% |
| OBI Pharma, Inc. | 650.44 Million TWD | 69.868% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 49.851% |
| Acepodia, Inc. | 384.47 Million TWD | 49.024% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -129.086% |